Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Express Scripts Holding Co.

www.express-scripts.com

Latest From Express Scripts Holding Co.

Pfizer, Express Scripts Clash Over Biosimilar Formulary Placement

Pfizer VP blames rebate strategies of innovators for difficulty in getting biosimilars on formularies while Express Scripts official says it is all about net cost during House hearing on lowering Rx drug prices.

Market Access Biosimilars

Amgen Resolves Repatha Access Kerfuffle With Express Scripts

On eve of congressional hearing, the pharmacy benefit manager assures Amgen that Repatha is available to its employees.

Market Access Commercial

Opioid Prescribing Guidelines: Public-Private Partnership Is Tackling Scope, Consequences

US Action Collaborative plans to align guidelines for acute and chronic pain indications; panelist at public meeting questions whether focus should be on pain management rather than opioids.

Policy Safety

Can Sanofi Catch Up With Amgen Now That Praluent Has CV Risk-Reduction Claim?

ODYSSEY Outcomes data added to US label for Praluent; update includes claim for reduced cardiovascular incident risk and trial data indicating an all-cause mortality benefit.

Cardiovascular Clinical Trials
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register